CD95 and Bcl-2 as a New Markers in Acute Lymphocytic Leukemia

CD95 and Bcl-2 as a New Markers in Acute Lymphocytic Leukemia


Marketed By :  LAP LAMBERT Academic Publishing   Sold By :  Kamal Books International  
Delivery in :  10-12 Business Days

₹ 4,396

Availability: Out of stock


Delivery :

5% Cashback on all Orders paid using MobiKwik Wallet T&C

Free Krispy Kreme Voucher on all Orders paid using UltraCash Wallet T&C
Product Out of Stock Subscription

(Notify me when this product is back in stock)

  • Product Description

Acute lymphocytic leukemia (ALL) is a malignant disorder common among children. Apoptosis or programmed cell death is greatly involved in the mechanism of cancer development as well as drug resistance to cancer and it is the primary mechanism through which most chemotherapeutic agents induce tumor cell death. Total leukocytic count, hemoglobin, platelet count and Bone marrow blast count were used for follow up of patients. CD95 % and Bcl-2 concentration used as a new markers. It was found that both CD95 % and Bcl-2 concentration are useful diagnostic markers that may help not only in diagnosis but also in follow up of ALL cases. However, further studies are still needed involving larger number of patients and comparing values at diagnosis with values after completing the whole treatment course. It's also recommended to give Zn supplement to children with ALL in order to achieve rapid and permanent recovery.

Product Specifications
SKU :COC97426
Country of ManufactureIndia
Product BrandLAP LAMBERT Academic Publishing
Product Packaging InfoBox
In The Box1 Piece
Product First Available On ClickOnCare.com2015-08-18
0 Review(s)